2017
Limited efficacy of HLA-haploidentical peripheral blood stem cell infusion in treatment of elderly patients with acute myelogenous leukaemia
ŠUSTKOVÁ, Zuzana; Ivana JEŽÍŠKOVÁ; Dana DVOŘÁKOVÁ; Ondřej HORKÝ; Lukáš SEMERÁD et. al.Basic information
Original name
Limited efficacy of HLA-haploidentical peripheral blood stem cell infusion in treatment of elderly patients with acute myelogenous leukaemia
Authors
ŠUSTKOVÁ, Zuzana (203 Czech Republic, guarantor); Ivana JEŽÍŠKOVÁ (203 Czech Republic); Dana DVOŘÁKOVÁ (203 Czech Republic, belonging to the institution); Ondřej HORKÝ (203 Czech Republic); Lukáš SEMERÁD (203 Czech Republic); Barbora WEINBERGEROVÁ (203 Czech Republic); Martin ČULEN (703 Slovakia, belonging to the institution); Jiří MAYER (203 Czech Republic, belonging to the institution) and Zdeněk RÁČIL (203 Czech Republic, belonging to the institution)
Edition
Hematological Oncology, Hoboken, Wiley-Blackwell, 2017, 0278-0232
Other information
Language
English
Type of outcome
Article in a journal
Field of Study
30204 Oncology
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
is not subject to a state or trade secret
References:
Impact factor
Impact factor: 3.193
RIV identification code
RIV/00216224:14110/17:00095793
Organization unit
Faculty of Medicine
UT WoS
000403677200014
EID Scopus
2-s2.0-84940522779
Keywords (in Czech)
akutní myeloidní leukémie; imunoterapie; starší pacienti
Keywords in English
acute myelogenous leukaemia; immunotherapy; elderly patients
Tags
Tags
International impact, Reviewed
Changed: 21/3/2018 16:31, Soňa Böhmová
Abstract
V originále
The study showed no benefit of adding HLA-haploidentical PBSC infusion to intensive chemotherapy over standard treatment in elderly AML patients.
Links
EE2.3.30.0037, research and development project |
|